awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33401352-302487E0-A556-47CA-ADB9-CDABABC84E1F
Q33401352-302487E0-A556-47CA-ADB9-CDABABC84E1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401352-302487E0-A556-47CA-ADB9-CDABABC84E1F
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer
P2860
Q33401352-302487E0-A556-47CA-ADB9-CDABABC84E1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401352-302487E0-A556-47CA-ADB9-CDABABC84E1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e79fa4aefef316ab0ae3e5aa4fe775d63138295
P2860
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity.